Model-free feature screening for categorical outcomes: Nonlinear effect detection and false discovery rate control
暂无分享,去创建一个
[1] D. Schadendorf,et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.
[2] Xihong Lin,et al. Variable selection and estimation in generalized linear models with the seamless ${\it L}_{{\rm 0}}$ penalty , 2012, The Canadian journal of statistics = Revue canadienne de statistique.
[3] John T. Wei,et al. Integrative molecular concept modeling of prostate cancer progression , 2007, Nature Genetics.
[4] Maria L. Rizzo,et al. Measuring and testing dependence by correlation of distances , 2007, 0803.4101.
[5] Mingzhu Zhu,et al. MEGO: gene functional module expression based on gene ontology. , 2005, BioTechniques.
[6] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[7] Christina Backes,et al. GeneTrail—advanced gene set enrichment analysis , 2007, Nucleic Acids Res..
[8] Qingyang Zhang,et al. Integrative network analysis of TCGA data for ovarian cancer , 2014, BMC Systems Biology.
[9] Weidong Liu,et al. Two‐sample test of high dimensional means under dependence , 2014 .
[10] Lipo Wang,et al. A Modified T-test Feature Selection Method and Its Application on the HapMap Genotype Data , 2008, Genom. Proteom. Bioinform..
[11] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[12] Č. Vlček,et al. Melanoma cells influence the differentiation pattern of human epidermal keratinocytes , 2015, Molecular Cancer.
[13] Peng Xiao,et al. Hotelling’s T 2 multivariate profiling for detecting differential expression in microarrays , 2005 .
[14] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] Erchin Serpedin,et al. Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer , 2012, BMC Genomics.
[16] Louis H. Y. Chen,et al. Stein's method for normal approximation , 2005 .
[17] Sayan Mukherjee,et al. Modeling Cancer Progression via Pathway Dependencies , 2008, PLoS Comput. Biol..
[18] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[19] M. Roudbaraki,et al. Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells , 2000, The Prostate.
[20] P. Rosenbaum. An exact distribution‐free test comparing two multivariate distributions based on adjacency , 2005 .
[21] Jun Zhang,et al. Robust rank correlation based screening , 2010, 1012.4255.
[22] Weidong Liu. Structural similarity and difference testing on multiple sparse Gaussian graphical models , 2017 .
[23] Veerabhadran Baladandayuthapani,et al. A Two-Sample Test for Equality of Means in High Dimension , 2015, Journal of the American Statistical Association.
[24] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[25] Xing-Ming Zhao,et al. Inferring gene regulatory networks from gene expression data by path consistency algorithm based on conditional mutual information , 2012, Bioinform..
[26] Peter R Hobson,et al. Computationally efficient algorithms for the two-dimensional Kolmogorov–Smirnov test , 2008 .
[27] J Gertheiss,et al. Variable selection in generalized functional linear models , 2013, Stat.
[28] R. Tibshirani,et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] Robert E. Tarjan,et al. Finding Minimum Spanning Trees , 1976, SIAM J. Comput..
[30] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[31] Hu Yang,et al. Robust variable selection for generalized linear models with a diverging number of parameters , 2017 .
[32] Hui Liu,et al. Detection of type 2 diabetes related modules and genes based on epigenetic networks , 2014, BMC Systems Biology.
[33] Qingyang Zhang,et al. A graph-based multi-sample test for identifying pathways associated with cancer progression , 2020, Comput. Biol. Chem..
[34] Bo Zhang,et al. Mathematical modelling of interacting mechanisms for hypoxia mediated cell cycle commitment for mesenchymal stromal cells , 2018, BMC Systems Biology.
[35] Z. Werb,et al. The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.
[36] Dag Tjøstheim,et al. NOTES AND CORRESPONDENCE A Cautionary Note on the Use of the Kolmogorov-Smirnov Test for Normality , 2007 .
[37] Jerome H. Friedman,et al. A New Graph-Based Two-Sample Test for Multivariate and Object Data , 2013, 1307.6294.
[38] Gábor J. Székely,et al. The distance correlation t-test of independence in high dimension , 2013, J. Multivar. Anal..
[39] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] Michael A. Newton. Introducing the discussion paper by Sz\'{e}kely and Rizzo , 2010 .
[41] Yixin Wang,et al. Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions , 2005, Clinical Cancer Research.
[42] J. Friedman,et al. Multivariate generalizations of the Wald--Wolfowitz and Smirnov two-sample tests , 1979 .
[43] E. Pikarsky,et al. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion , 2014, Oncotarget.
[44] Weidong Liu. Gaussian graphical model estimation with false discovery rate control , 2013, 1306.0976.
[45] Peter J. Woolf,et al. GAGE: generally applicable gene set enrichment for pathway analysis , 2009, BMC Bioinformatics.
[46] H. Crutcher. A Note on the Possible Misuse of the Kolmogorov-Smirnov Test , 1975 .
[47] Paul Pavlidis,et al. ErmineJ: Tool for functional analysis of gene expression data sets , 2005, BMC Bioinformatics.
[48] K. Hoek,et al. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas , 2005, Cancer biology & therapy.
[49] Patrik Edén,et al. Comparing Functional Annotation Analyses with Catmap Comparing Functional Annotation Analyses with Catmap , 2004 .
[50] Muni S. Srivastava,et al. A two sample test in high dimensional data , 2013, Journal of Multivariate Analysis.
[51] Alfonso Valencia,et al. EnrichNet: network-based gene set enrichment analysis , 2012, Bioinform..
[52] Joshy George,et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.
[53] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[54] Seon-Young Kim,et al. PAGE: Parametric Analysis of Gene Set Enrichment , 2005, BMC Bioinform..